Astellas Receives European Commission Approval for
Roxadustat is the first orally administered hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) inhibitor available for adult patients with anemia...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Anna Otten. Real-time updates on events, politics, business and more.